Stock fact sheet · data as of
IDenta Corp. (IDTA): fair value, margin of safety and Wheel Score
Healthcare · Medical - Specialties · Israel · Value
Is IDTA undervalued?
IDenta Corp. (IDTA) closed at 0.3500 on 16 Oct 2026. The GLS average fair value - the simple average of the 8 valuation models that produced a positive number - is 0.5417, which puts the price 35% below it. 6 of the 8 models value the shares above the current price. A gap this wide is rare in our universe of ~7,400 US stocks and is exactly what the Value part of the Wheel Score rewards; it is also where the question "why is it this cheap?" matters most.
The 8 models disagree widely: GLS Growth gives 0.0957 while 10 Cap gives 1.23. A spread that wide means the average is sensitive to which methods you trust; the model table below shows where each one lands, and the Quote page lets you switch any of them off.
The nightly engine files IDTA under Value: positive earnings at a P/E of 18 or less.
Nine valuation models for IDTA
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | 0.3922 | +12% | Present value of the projected free cash flows, discounted at the cost of capital |
| Graham Number | 0.4709 | +35% | The most a defensive investor pays for the earnings and book value per share |
| Graham Growth | 0.5274 | +51% | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields |
| Lynch | 0.1308 | -63% | EPS × the earnings growth rate (PEG of 1), growth capped at 25% |
| GLS Growth | 0.0957 | -73% | EPS compounded ten years at the blended growth rate, discounted back at 15% a year |
| 10 Cap | 1.23 | +251% | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10% |
| Payback Time | 1.13 | +222% | Eight years of compounded free cash flow: the price at which the business pays for itself |
| DDM | - | - | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight |
| EPV | 0.3633 | +4% | Earnings power value: current EPS capitalised at 9% with no growth |
| Zombie (liquidation) | 0.1278 | -63% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 0.0000 | -100% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
Financial health is average - IDTA passes 6 of the nine Piotroski tests, which passes the Sunday Scan's "6 or more" rule. The Financials tab on the Quote page shows which tests fail. The GLS Moat score is low at 2.5 out of 10, which says the ten-year record of revenue, earnings, margins and returns on capital has been inconsistent - growth and shocks rather than steady compounding.
Returns on capital are moderate - ROIC 6.5%, ROE 11.3%, ROA 5.2% - with debt at 0.73 times equity and a free-cash-flow yield of 17.9%.
IDenta Corp. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain.
Institutional ownership scores 5/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.
| Piotroski F-score | 6 / 9 | ROIC | 6.5% |
|---|---|---|---|
| GLS Moat | 2.5 / 10 | ROE | 11.3% |
| Debt / equity | 0.73 | ROA | 5.2% |
| Free-cash-flow yield | 17.9% | Payout ratio | 0% |
| Institutions | 5 / 10 | Insiders · Congress | 5 · 5 / 10 |
Wheel Score 39: No options
IDTA has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business; the Wheel Score is capped at 39 and shown as "No options" (39 here). The valuation and quality numbers still apply to owning the shares outright.
Volume runs at 1k shares a day on a market cap of $1M, with a beta of 0.62 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 6 of 20.
| Part | Points | From | |
|---|---|---|---|
| Value | 25 / 25 | 35% margin of safety | |
| Health | 13 / 20 | Piotroski 6/9 | |
| Moat | 4 / 15 | moat 2.5/10 | |
| Premium | 0 / 20 | no option data | |
| Stability | 6 / 20 | 1k shares/day, $1M cap, beta 0.62 |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.
Upcoming events
No upcoming earnings date is recorded for IDTA in the nightly calendar.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Medical - Specialties
The 12 companies below are the closest to IDenta Corp. by market cap within the Medical - Specialties industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| WOK WORK Medical Technology Group Ltd. Class A | 1.35 | - | - | 29No options | $3M |
| BEAT HeartBeam, Inc. | 0.4315 | 0.1033 | -318% | 20No options | $24M |
| ITOC iTonic Holdings Ltd. | 4.01 | 0.5851 | -585% | 10No options | $27M |
| MDAI Spectral AI, Inc. | 1.54 | - | - | 24No options | $50M |
| DRIO DarioHealth Corp. | 5.13 | 119.64 | +96% | 39No options | $50M |
| SKIN SkinHealth Systems Inc. | 11.56 | 67.34 | +83% | 45Weak | $75M |
| APYX Apyx Medical Corporation | 2.56 | - | - | 35Weak | $108M |
| NYXH Nyxoah S.A. | 1.19 | - | - | 26No options | $121M |
| TRIB Trinity Biotech plc | 6.61 | - | - | 26Weak | $134M |
| LAB Standard BioTools Inc. | 0.6584 | - | - | 36Weak | $258M |
| MOBI Mobia Medical, Inc. Common Stock | 8.31 | - | - | 22No options | $277M |
| ANIK Anika Therapeutics, Inc. | 20.69 | 2.47 | -737% | 40Weak | $277M |
Screen the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about IDTA
Is IDTA undervalued right now?
By the GLS models, yes: at 0.3500 the stock is 35% below the average fair value of 0.5417 (data as of 16 Oct 2026). Whether the discount is deserved is the question to research next.
What is the Wheel Score of IDTA and what does it mean?
IDTA has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".
What is the GLS fair value for IDTA?
0.5417 per share as of 16 Oct 2026 - the simple average of the 8 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does IDenta Corp. report earnings next?
No upcoming earnings date is recorded for IDTA in our calendar as of 16 Oct 2026; the Calendars page is refreshed every morning.
Does IDTA have listed options, and how liquid are they?
No. The nightly options snapshot found no listed contracts on IDTA, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.